Le Lézard
Classified in: Health, Science and technology
Subjects: Conference Call, Webcast

Applied DNA to Present at the Imperial Capital 2020 Security Investor Conference on December 3


Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that it is scheduled to participate virtually in the Imperial Capital 2020 Security Investor Conference on Thursday, December 3, 2020. Dr. James A. Hayward, chief executive officer, will present at 10:45 a.m. EST that day and host one-on-one meetings throughout the day.

An archived webcast will be available within 24 hours of the live presentation on the "IR Calendar" section of the Applied DNA Investor Relations page at adnas.com.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates.

Visit adnas.com for more information. Follow us on Twitter and LinkedIn. Join our mailing list.

The Company's common stock is listed on NASDAQ under ticker symbol ?APDN', and its publicly traded warrants are listed on OTC under ticker symbol ?APPDW'.

Applied DNA is a member of the Russell Microcap® Index.


These press releases may also interest you

at 21:42
BioLineRx Ltd. , a late clinical-stage biopharmaceutical company focused on oncology, today announced that due to demand, the underwriter has agreed to increase the size of the previously announced offering and purchase on a firm commitment basis...

at 21:33
Genesis MedTech Group has reached a consensus to fully acquire Hua Medtech as part of its plans to set up a specialised neurovascular franchise, which has entered into a strategic cooperation with Penumbra, Inc., an NYSE listed, global healthcare...

at 20:55
Kiromic BioPharma, Inc. , an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel oncology therapeutics, has announced the completion and...

at 20:00
Lucid Audio® announces the launch of Engagetm? to evolve hearing healthcare as we know it. Welcome to unrivaled clarity of speech, high-resolution Bluetooth streaming, and industry-leading rechargeable technology delivered directly to your door....

at 19:00
LabMinds®, Inc., a pioneer in automation for solution preparation in life sciences, today announced that the Revo has been approved for use in a Good Manufacturing Practice (GMP) certified laboratory in a Top 10 Pharmaceutical company. LabMinds is...

at 18:26
A rapidly growing IV therapy franchise is set for tremendous growth in 2021 and beyond. THE DRIPBaR, which currently has more than...



News published on 27 november 2020 at 10:40 and distributed by: